UCL  IRIS
Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Publication Detail
Cost‐effectiveness analysis of English memory assessment services two years after first consultation for patients with dementia
Abstract
OBJECTIVES: This paper aims to compare changes over two years in patients' health-related quality of life (HRQL) with the health and social care costs of diagnosis and treatment of people newly referred to MAS. METHODS: We analysed observational data from 1318 patients referred to 69 MAS who completed resource use and HRQL questionnaires at baseline, 3, 6, 12 and 24 months. We reported mean differences in HRQL (disease-specific DEMQOL and generic EQ-5D-3L), quality-adjusted life years (QALYs), costs and cost-effectiveness between baseline and 2-year follow-up. RESULTS: Two years after referral to MAS, patients reported a higher DEMQOL score (mean gain 4.47, 95% confidence interval: 3.08 to 5.90) and EQ-5D-3L (0.014, -0.011 to 0.039). Mean total costs and QALYs over 24 months was £2 411 (£1721 to £2873) and 0.027 (0.003 to 0.051), respectively. Assuming that patients' HRQL would not have altered over the two years had they not attended MAS, these outcomes suggest an incremental cost-effectiveness ratio of £89 546 (£38123 to £145864) based on changes in EQ-5D-3L. If we assumed that patients' HRQL would have declined by about 10% over this period had they not attended MAS, the cost-effectiveness ratio would be £25 056. The largest MAS (N=32; 46%) with over 50 new patients a month were more likely to be cost-effective than smaller ones (p < 0.01). CONCLUSIONS: Memory assessment services are effective and can be cost-effective for diagnosing and treating people with suspected dementia. Large variations in costs between clinics suggest that many MAS could improve their cost-effectiveness.
Publication data is maintained in RPS. Visit https://rps.ucl.ac.uk
 More search options
UCL Researchers
Author
Applied Health Research
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by